title: Intranasal administration of delta sleep-inducing peptide increases P300.
authors.forename: P
authors.initials: P
authors.lastname: Hruz
authors.forename: S
authors.initials: S
authors.lastname: Zechner
authors.forename: D
authors.initials: D
authors.lastname: Heimberg
authors.forename: V
authors.initials: V
authors.lastname: Hobi
authors.forename: G A
authors.initials: GA
authors.lastname: Schönenberger
authors.forename: K
authors.initials: K
authors.lastname: Scheffler
authors.forename: F
authors.initials: F
authors.lastname: Müller-Spahn
authors.forename: E
authors.initials: E
authors.lastname: Seifritz
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D018592:Cross-Over Studies; D003701:Delta Sleep-Inducing Peptide / Q000008:administration & dosage*; D004311:Double-Blind Method; D018913:Event-Related Potentials, P300 / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009293:Opioid-Related Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
chemical_list: D003701:Delta Sleep-Inducing Peptide